Embla Medical hf. (CPH:EMBLA)

Embla Medical Revenue

Embla Medical had revenue of $249.58M USD in the quarter ending September 30, 2026, with 5.40% growth. This brings the company's total for the last twelve months to $997.24M, up 11.20% year-over-year. In the year 2025, Embla Medical had annual revenue of $928.69M with 8.63% growth. That makes Embla Medical the 7,694th largest company in the world by revenue and 37th in Denmark.

• Revenue (ttm): $997.24M
• Revenue Growth: +11.20%
• P/S Ratio: 1.72
• Revenue / Employee: $221.61K
• Employees: 4,500
• Market Cap: 11.29B DKK

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue by Segment

By Segment

Chart

• Prosthetics & Neuro Orthotics 513.41M 53.1%
• Patient Care 305.93M 31.6%
• Bracing and Supports (Incl.Compression Therapy (Phlebology)) 148.38M 15.3%

By Geography

Chart

• Europe Middle-East and Africa (EMEA) 1.07B 60.0%
• Americas 635.09M 35.6%
• Asia-Pacific (APAC) 78.06M 4.4%

Fiscal year ended Dec 31, 2025 See the full Embla Medical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	928.69M	73.80M	8.63%
Dec 31, 2024	854.89M	69.21M	8.81%
Dec 31, 2023	785.68M	67.03M	9.33%
Dec 31, 2022	718.65M	-19.00K	-
Dec 31, 2021	718.67M	89.17M	14.16%

Data Source: S&P Global Market Intelligence Last updated: Oct 20, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error